Angelika Vlachou

Angelika Vlachou is an experienced professional currently serving as a Board Member at GQ Bio Therapeutics and smartbax, as well as a Partner at High-Tech Gründerfonds since July 2021. With a background in interim management and consulting for Biotech, MedTech, and Pharma companies, Angelika Vlachou specializes in financial and strategic planning, business development, and market entry strategies. Ongoing board memberships include faCellitate, Kupando GmbH, and past roles at Caterna and 4TEEN4 Pharmaceuticals GmbH. Angelika Vlachou holds a PhD in Medical Virology and Molecular Biology from Justus-Liebig-Universität Gießen, where the final grade was “summa cum laude,” as well as an MBA in BioMedTech from the University of Potsdam.